Vitrase ISTA Pharmaceuticals, Inc. - Treatment for Spreading Agent
Vitrase is a proprietary formulation of highly purified, preservative-free ovine hyaluronidase indicated for use as a spreading agent to facilitate the dispersion and absorption of other drugs.Posted: May 2004
Related articles
- Review of ISTA Pharmaceuticals' New Drug Application for Vitrase for Use as a Spreading Agent Extended 90 Days by FDA - February 6, 2004
Vitrase (hyaluronidase) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
